Melanoma

>

Latest News

Similar Efficacy in Melanoma Shown in Indirect Comparison of PD-1/LAG3 vs PD-1/CTLA-4
Similar Efficacy in Melanoma Shown in Indirect Comparison of PD-1/LAG3 vs PD-1/CTLA-4

July 16th 2024

During a Case-Based Roundtable® event, Michael A. Postow, MD, discussed an indirect treatment comparison of nivolumab plus relatlimab vs nivolumab plus ipilimumab in patients with advanced melanoma in the first article of a 2-part series.

Neoadjuvant Immunotherapy Trial Sees High pCR Rates in Stage III Melanoma
Neoadjuvant Immunotherapy Trial Sees High pCR Rates in Stage III Melanoma

July 15th 2024

FDA Fast Tracks Innovative TIL Therapy OBX-115 in Advanced Melanoma
FDA Fast Tracks Innovative TIL Therapy OBX-115 in Advanced Melanoma

July 11th 2024

EFS Benefit of Pembrolizumab Is Shown  in Neoadjuvant, Adjuvant Setting
EFS Benefit of Pembrolizumab Is Shown in Neoadjuvant, Adjuvant Setting

June 27th 2024

Phase 3 Study of Novel Immunotherapy Combo Offers Promise in Advanced Melanoma
Phase 3 Study of Novel Immunotherapy Combo Offers Promise in Advanced Melanoma

June 22nd 2024

Video Series
Video Interviews
Podcasts

More News